Boehncke, Wolf-Henning
Biologics in General Medicine
1. Introduction: Definition and Classification of Biologics
W. -H. Boehncke, H. H. Radeke
Part I. Development and Pre-clinical Pharmacology of Biologics
2. Infliximab: From the Idea to the Product
M. Wiekowski, Ch. E. Antoni
3. Adalimumab
J. Salfeld, H. Kupper
4. Etanercept
Ch. T. Molta
5. Efalizumab: Antibody Characteristics, Mode of Action and Preclinical Development
S. Jahn, K. Schmitt-Rau
6. Monoclonal Antibody Targeted Radiation Cancer Therapy
L. M. M. Keller, C. A. Boswell, D. E. Milenic, E. D. Brady, M. W. Brechbiel
7. The Production of Biopharmaceuticals
B. Hughes, L. E. Hann
Part II. Disease-Specific Applications and Clinical Trials
8. Treating Autoimmune Bullous Skin Disorders with Biologics
R. Eming, A. Niedermeier, M. Pfütze, A. Jacobi, M. Hertl
9. Biologics in Psoriasis
W. A. Myers, W. -H. Boehncke, A. B. Gottlieb
10. Biologic Agents in Psoriatic Arthritis
P. Mease
11. Biologic Therapies for Rheumatoid Arthritis Targeting TNF-a and IL-1
P. C. Taylor
12. Biologics in Crohn’s Disease and Ulcerative Colitis: Focus on Tumor Necrosis Factor Antagonists
J. Salfeld, P. Rutgeerts
13. Multiple Sclerosis: New Immunobiologics
R. Gold, R. Hohlfeld
14. Biologics in Cutaneous Lymphoma
M. Beyer, Ch. Assaf, W. Sterry
15. Biologics in Targeted Cancer Therapy
D. Schrama, J. C. Becker
Part III. Safety and Perspectives
16. Safety Aspects of Biologics: Lessons Learnt from Monoclonal Antibodies
C. K. Schneider, J. Löwer
17. New Biological Therapeutics in the Genome Age
T. N. C. Wells, S. Schnieper-Samec
18. Evidence Based Medicine’s Perspective on Biologics
B. Rzany, A. Nast
DRM-restrictions
Printing: not available
Clipboard copying: not available
Keywords: MEDICAL / Public Health MED078000
- Author(s)
- Boehncke, Wolf-Henning
- Radeke, Heinfried H.
- Publisher
- Springer
- Publication year
- 2007
- Language
- en
- Edition
- 1
- Category
- Medicine, Health Care, Mode
- Format
- Ebook
- eISBN (PDF)
- 9783540290186